Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Autoimmune markers linked to lower corneal nerve density in neurotrophic keratopathy
  • Neurotrophic Keratitis

Autoimmune markers linked to lower corneal nerve density in neurotrophic keratopathy

Kelsey Moroz

Patients with neurotrophic keratopathy (NK) with positive autoimmune serology have significantly lower corneal nerve density compared to those without autoimmune markers, according to a poster presented at the 2025 World Cornea Congress.

Researchers analyzed data from 31 adult patients who had available autoimmune serology and IVCM imaging.

Overall, 66.7% of patients tested positive for ≥1 autoimmune marker, with antinuclear antibodies being the most common (61.3%), followed by rheumatoid factor (16.1%) and Anti-Ro (16.1%). Patients with positive autoimmune markers had significantly lower total corneal nerve density (median: 0.09 mm/mm²) compared to those without (median: 2.53 mm/mm²; P = 0.033).

The findings suggest that autoimmune-related NK may be associated with greater corneal nerve damage.

Reference
Balbuena-Pareja A, et al. Lower Corneal Nerve Density Observed in Neurotrophic Keratopathy Patients with Positive Autoimmune Markers. Poster presented at: 2025 World Cornea Congress; March 20-22, 2025; Washington, DC.

Share

Related Content

  • Neurotrophic Keratitis

Serial DBM grafting improves outcomes in early neurotrophic keratitis

  • Neurotrophic Keratitis

Autologous serum eye drops improve symptoms and corneal nerve parameters in neurotrophic keratitis

  • Practice Management

AOA 2026: What is the best IOL for my patient?

  • Glaucoma

AOA 2026: Surgical and technological advances to improve quality of life and reduce drop burden in glaucoma

  • Neurotrophic Keratitis

Cenegermin improves corneal healing in moderate to severe neurotrophic keratitis

  • Neurotrophic Keratitis

Shelf-stable amniotic membrane improved outcomes in early-stage neurotrophic keratopathy

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon